A Study of Subcutaneously Administered Herceptin (Trastuzumab) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Hoffmann-La Roche
Related studies linked through entity extraction aliases.
A Study of Subcutaneous At Home Administration of Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2-positive (HER2+) Early Breast Cancer (eBC)
- Status
- COMPLETED
- Phase
- PHASE3
A Screening Study To Assess The Cognition Status in Healthy Volunteers
- Status
- COMPLETED
- Phase
- N/A
A PET Study With RO5545965 in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Study in Participants With Asthma Initiating Treatment With Omalizumab (Xolair)
- Status
- COMPLETED
- Phase
- PHASE4
Avastin+ GemAOD As First-Line Treatment in NK/T Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Retrospective, Observational Study of RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- N/A
A Screening Protocol to Assess Adults and Adolescents With Down Syndrome for Eligibility For Upcoming Study of RG1662 (Study BP27832)
- Status
- COMPLETED
- Phase
- N/A
U-Act-After: An Observational Study on Long-Term Efficacy of Tight Control RoActemra/Actemra (Tocilizumab) and/or Methotrexate in Patients With Early Rheumatoid Arthritis Who Have Participated in the U-Act-Early Study (ML22497)
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate Lumretuzumab in Combination With Pertuzumab and Paclitaxel in Participants With Metastatic Breast Cancer Expressing Human Epidermal Growth Factor Receptor (HER) 3 and HER2 Protein
- Status
- COMPLETED
- Phase
- PHASE1
Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of RO6870868 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Multi-Line Therapy Trial in Unresectable Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Vemurafenib (Zelboraf) in Chinese Participants With BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Collect Blood Samples From Patients With Spinal Muscular Atrophy for Biomarker Analysis
- Status
- COMPLETED
- Phase
- N/A
A Safety and Efficacy Study of Obinutuzumab Alone or in Combination With Chemotherapy in Participants With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Subcutaneously (SC) Administered Tocilizumab (TCZ) in Participants With Polyarticular-Course Juvenile Idiopathic Arthritis (pJIA)
- Status
- COMPLETED
- Phase
- PHASE1
A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - "POPLAR"
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Setrobuvir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Genotype 1 Chronic Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE2